Parkinsonism & Related Disorders

Article	Citations
Malignant Neuroleptic Syndrome in a Patient with Huntington's Disease	116
Error-based biofeedback for gait training in Parkinson's disease	84
Dual Phase 18F-FP-CIT PET in presynaptic and trans-synaptic nigrostriatal dysfunction in Multiple System Atrophy	80
APOE carrier status and cognitive outcomes after STN-DBS surgery for Parkinson’s disease.	67
A case of probable Progressive Supranuclear Palsy Frontal type (PSP-F) presenting as psychosis	66
Leveraging Telehealth and Wearables for Parkinson’s Disease: Innovative Approaches to Enhance Personalized Care	66
Effect of ND0612 Continuous Infusion on Motor Performance and Experiences of Daily Living in Patients With Parkinson’s Disease	60
Early-onset Parkinson's disease, regional and national burden, and its attributable risk factors in 204 countries and regions from 1990 to 2021: Results from the global burden of disease study 2021	58
Neurocognition, Cerebellar Functions and Psychiatric Features in Spinocerebellar Ataxia Type 34	57
FindPD.DaT: Development of a Novel Artificial Intelligence-driven Tool for Diagnosis of Parkinson’s Disease using Dopamine Transporter Scans	55
Effects of an intensive, multidisciplinary rehabilitative treatment in an outpatient setting on clinical outcomes in Parkinson’s Disease: preliminary results.	53
Perioperative quantification of MDS-UPDRS-III tremor measurements in patients with Parkinson’s Disease using accelerometry	53
β-Caryophyllene decreases neuroinflammation and exerts neuroprotection of dopaminergic neurons in a model of hemiparkinsonism through inhibition of the NLRP3 inflammasome	39
Association between serum lipid levels and dopamine loss in idiopathic rapid eye movement sleep behavior disorder	39
Fear among patients with Parkinson's disease and repeated falls: Analysis of skin conductance responses during simulated accidents	38
Symptom onset lateralization and bilaterality in Parkinson's disease: Clinical implications of motor and non-motor profiles	37
Cognitive impairment in REM-sleep behaviour disorder and individuals at risk of Parkinson's disease	35
Hemiatrophy-hemiparkinsonism and Poland syndrome: A causative or coincidental association?	34
Leigh-like syndrome as a presentation of biallelic variants in DNAJC30 gene with predominant putamen degeneration and limb dystonia	33
Apomorphine sublingual film for “OFF” episodes in Parkinson’s disease: analysis of baseline factors	32
Critical Appraisal of Economic Evaluation of Biomarkers Used for Screening of Dementia	32
Bilateral Hemimasticatory spasm in a patient with hypereosinophilic syndrome	32
White matter connectivity networks predict early dementia conversion in Parkinson’s disease	30
A novel summary index derived from Kinect to evaluate the severity of postural abnormalities in patients with Parkinson’s Disease	30
Perry disease in an Argentine family due to the DCTN1 p.G67D variant	29

Early onset hemichorea-parkinsonism with POLG mutation without external ophthalmoplegia responsive to pallidal DBS	29
Cerebello-thalamofrontal dysconnectivity in paroxysmal kinesigenic dyskinesia: A resting-state fMRI study	29
Examination of cognitive function in Parkinson's disease patients with chronic kidney disease	28
Chorea-Acanthocytosis: A Case Report	28
Association of Baseline Serum Urate Levels with Longitudinal General Cognition in Non-Demented Parkinson's Disease	28
Role of linagliptin, a dipeptidyl peptidase-4 inhibitor against oxidative stress and neuronal damage in experimental diabetic aging brain of female rats of different age groups.	27
Targeting sedentary behavior decreases depressive symptoms and improves sleep in people with Parkinson’s Disease	27
Association and Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson’s Disease–related Cognitive Impairment	27
“Pop-up” studies: Observational studies in Huntington disease conducted at annual family convention	27
The effects of stretching in Parkinson's disease: A systematic review of randomized controlled trials	26
Fibrinogen exacerbates GCase ubiquitination via ATF5-induced TRIP12 activation in Parkinson's Disease	26
Treatment of refractory post-hypoxic myoclonus and focal epilepsy with subthalamic nuclei deep brain stimulation	26
Asymmetric Parkinsonism and Ataxia with autonomic dysfunction and RBD	26
Prevalence and clinical impact of alpha-synuclein pathology in idiopathic normal pressure hydrocephalus: Insights from RT-QuIC assay	25
Diagnosis of vascular parkinsonism: A new tool for gait hypokinesia occurring in older persons	25
Longitudinal brain changes in Parkinson's disease with severe olfactory deficit	25
Evaluation of mild cognitive impairment in older patients with essential tremor	23
Integrity of Dopaminergic Terminals in the Caudate Nucleus Modulates Rest Tremor in Parkinson’s Disease	23
Relation between Clinical and Electrophysiological Correlates of Peripheral Polyneuropathy and Oral Levodopa Treatment in People with Parkinson’s Disease	23
Is rapid eye movement sleep behavior disorder a marker of Parkinson's disease severity?	22
Objective sleep enhancement in Parkinson's disease: A sham-controlled trial of low-frequency repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex	22
Digital devices and wearable technology for quantification of freezing of gait in adolescents with pediatric movement disorders attending school	22
Establishing a framework for quality of inpatient care for Parkinson's disease: A study on inpatient medication administration	22
Magnetic resonance spectroscopy reveals evidence of brain oxidative stress in Tourette syndrome	22
Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study	22
Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?	21
Foslevodopa/foscarbidopa subcutaneous infusion maintains equivalent levodopa exposure to levodopa-carbidopa intestinal gel delivered to the jejunum	21
Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and 123I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson's disease: Multivariate analyse	21
A useful cognitive motor dual task paradigm in prodromal and manifest Huntington’s disease	21
Psychometric analysis of the short form UCLA Loneliness Scale (ULS-8) in people with Parkinson's disease	21
Postural abnormalities in Asian and Caucasian Parkinson's disease patients: A multicenter study	21
Diet quality and prodromal Parkinson's disease probability in isolated REM sleep behavior disorder	20
Study of 17β estradiol with neuropeptide and amyloid beta fragment on neuronal and biochemical functions in naturally menopausal aging rats	20
Huntington Disease – Update on Recent Advances and a Look Toward the Future	20
Machine Learning Analysis of the Interaction Between miR-155 and LRRK2 Gene Variants in Parkinson's Disease Progression	20
Mitochondrial and autophagic dysfunctions of skin fibroblasts derived from pantothenate kinase-associated neurodegeneration patients carrying PANK2 mutations and the rescuing effects of allantoin	20
The Elevated Risk of Dementia in Parkinson's Disease Patients Associated with Metabolic Syndrome	20
Unveiling the Complexity of Parkinson's Disease: Exploring Subtypes and Tracing its Five-Stage Natural Course	20
Assessment of SLC25A46 variants in idiopathic Parkinson’s disease	20
Retinal microvascular impairment in Parkinson's disease with cognitive dysfunction	20
Clinical Evaluation of Parkinson's Disease Patients Admitted to the Movement Disorders Outpatient Clinic of Istanbul Taksim Training and Research Hospital, Turkey, 2023	20
Efficacy of Once-Daily Valbenazine in Adults with Chorea Associated with Huntington’s Disease: Effect Size Over Time	19
Somnolence-Related Events Over Time During Valbenazine Treatment for Chorea Associated with Huntington’s Disease	19
Parkinson’s Disease with Hyposmia and Dysautonomia: Does It Represent a Distinct Subtype?	19
Hereditary Spastic Paraparesis with SPG6 mutation: First case report from Malaysia	19
Association between global cognitive function and autonomic dysfunction in patients with de novo Parkinson’s disease	19
Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism	19
The characteristic and prognostic role of blood inflammatory markers in patients with Huntington's disease from China	19
The role of neurotrophic factors in development Parkinson's disease dementia	19
Establishing exercise habits in patients with Parkinson's disease through an exercise group model	19

Atypical Presentation of Autosomal Recessive Cerebellar Ataxia Type I Mimicking Amyotrophic Lateral Sclerosis	18
Association of bilateral oophorectomy with incidence of Parkinson's disease: A systematic review and meta-analysis	18
Editorial Board	18
Commentary on “The use of hypoglycemic drugs in Parkinson's disease: An updated meta-analysis of randomized controlled trials”	18
Impact of inpatient mobility on outcomes in Parkinson's disease	18
Gerstmann-Straussler-Scheinker disease: Lessons from two new Indian kindreds	18
Colony-Stimulating Factor-1 Receptor-Related Disorders in the Hispanic Population: A Report of six Families	17
The BEACON Study: LRRK2 inhibition by BIIB122/DNL151 in participants with Pathogenic LRRK2 Variants and Parkinson’s disease	17
From writer's cramp to blepharoclonus: An atypical journey with a novel KMT2B variant	17
Functional movement disorders in dopa-responsive dystonia	17
Cystatin C as a Biomarker for the Development of Parkinson disease in Patients with Chronic Kidney Disease	17
A young man with progressive dysarthria, generalized slowness and memory loss	17
Augmented reality cueing for freezing of gait: Reviewing an emerging therapy	17
Differences in progressive supranuclear palsy in patients of Asian ancestry?	17
Protective Lifestyle Risk Factors Against Parkinson’s Disease In Sub-Saharan Africa: A Review On Current Evidence	17
Dentate calcifications with palatal tremor and facial myorhythmia in adult-onset Cerebral X-linked Adrenoleukodystrophy	17
Personality assessment with Temperament and Character Inventory in Parkinson's disease	17
Alterations in electrochemical skin conductance as a marker of autonomic dysfunction in multiple system atrophy	16
On demand inhaled levodopa in Parkinson´s disease (pd) patients with device assisted therapies	16
A late-onset neurological disorder: Is progression inevitable? Expert Commentary	16
Sex differences for cognitive decline in progressive supranuclear palsy	16
¿It Is Any Difference Between Directional Vs Omnidirectional Lead For Treatment In Parkinson Disease?	16
Effect of Safinamide on Non-motor symptoms and QoL According to Sex, Age, Disease Duration and Levodopa Equivalent Daily Dose	16
Expanding the phenotypic and genotypic spectrum of DYT-TUBB4A with seven patients from India	16
The distinctive functional connectivity of the cholinergic nucleus basalis of Meynert in Parkinson’s disease across different cognitive status	16
Proteomic profile of saliva in patients with Parkinson's disease after the practice of interval exercise	16
Editorial Board	16
Dopaminergic dysfunctions instigated by Nano-formulation of Neonicotinoid pesticides in mice	16
Distractibility predicts favourable response of functional tremor to transcranial magnetic stimulation: An electrophysiological study	16
Editorial Board	16
Efficacy and safety of high doses of safinamide in advanced Parkinson disease	16
Levodopa, homocysteine and Parkinson's disease: What's the problem?	15
Machine Learning-based World Health Organization Disability Assessment Schedule for persons with Parkinson's disease	15
Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis	15
Long-term incobotulinumtoxinA treatment for chronic sialorrhea: efficacy and safety over 64 weeks	15
Tardive dyskinesia versus tardive syndrome. What is in a name?	15
Frequency settings of subthalamic nucleus DBS for Parkinson's disease: A systematic review and network meta-analysis	15
Diverse paths of phenotypic evolution in functional movement disorders: A longitudinal perspective	15
Genetic overlap between dystonia and other neurologic disorders: A study of 1,100 exomes	15
Atypical antipsychotic use and mortality risk in Parkinson disease	15
Segmental dystonia as the prominent phenotype resulting from a MICU1 splice variant in a new Indian case	15
Diagnostic performance of T1-Weighted MRI gray matter biomarkers in Parkinson's disease: A systematic review and meta-analysis	15
Cognitive and neuropathological contributions to gait dysfunction in Parkinson's disease	15
The impact of anti-inflammatory therapy on Parkinson's disease incidence: A retrospective cohort study	15
Brittle dyskinesias after bilateral STN DBS: dissociation of microlesioning effect on tremor versus on dyskinesias	15
Wearable sensors for assessing disease severity and progression in Progressive Supranuclear Palsy	15
Single-dose intranasal administration of α-syn PFFs induce lewy neurite-like pathology in olfactory bulbs	14
Motor and non-motor responses of STN DBS in early onset PLA2G6 related Parkinsonism with compound heterozygous mutation from China	14
MRI index of glymphatic system mediates the influence of locus coeruleus on cognition in Parkinson's disease	14
The factors for choosing intesticular gel therapy	14
REM density in Parkinson’s disease: Effects of motor, cognitive, and autonomic function, and the impact of evening dopaminergic medication	14
The MemTrax memory test for detecting and assessing cognitive impairment in Parkinson's disease	14
Genetic study of early-onset Parkinson's disease in the Malaysian population	14
Introducing Virtual Shared Medical Appointments as a Novel Treatment Platform for Functional Movement Disorders	14
Neuropsychological studies in children with tic hyperkinesis	14
Phenotypic manifestations of KIF5A Arg1007Lys mutation: A large kindred study	14
Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's disease	14
A de novo GRIA3 variant with complex hyperkinetic movement disorder in a girl with developmental delay and self-limited epilepsy	14
Effect of eight-week online cognitive training in Parkinson's disease: A double-blind, randomized, controlled trial	14
Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN) Presenting With Parkinsonism Findings: A Case Report	14
ERCC4 variants causing neurodegeneration with ataxia and chorea in three siblings in Lithuanian family	14
Identification of the needs of patients with Parkinson’s disease through a qualitative research process	13
Cropland associated with risk of Parkinson's disease in the northern Great Plains	13
Spinocerebellar ataxia subtype 40: Report of a case and review of literature	13
Transcranial high-intensity Magnetic Resonance-guided focused ultrasound (tcMRgFUS) – safety and impacts on tremor severity and quality of life	13
Interaction between caffeine intake and polymorphisms of PARK16 modifies Parkinson’s Disease risk	13
Post-COVID parkinsonism: A scoping review	13
The role of semispinalis capitis muscles in cervical dystonia with goose-neck posture	13
Recent advances in non-Huntington's disease choreas	13
Longitudinal evaluation of patients with isolated head tremor	13
Sexual dysfunction in patients with focal dystonia	13
Convergence insufficiency and Parkinson's disease progression	13
Association between global cognitive function and autonomic dysfunction in patients with de novo Parkinson’s disease	13
Improvement of non-motor symptoms with NE3107 adjunctive to Carbidopa / Levodopa in patients with Parkinson`s disease: A Phase 2A, placebo-controlled study	13
Cerebellar blood perfusion is a diagnostic, but not a prognostic, marker for parkinsonian-dominant type multiple system atrophy	13
Sweet as Parkinson's disease: Rethinking the impact of diabetes mellitus	13
Correcting vertical perception to reverse Pisa syndrome in Parkinson's disease: A case report	13
The feasibility of using loss of “swallow tail sign” on 3T – susceptibility weighted MRI in diagnosis of Parkinson’s disease	12
Thyroid disease in cervical dystonia	12
Tremor is associated with familial clustering of dystonia	12

Seronegative basal ganglia encephalitis mimicking dementia of Lewy body	12
Cognitive function, psychobehavioral symptoms, and MRI features in patients with non-demented Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies	12
Fecal tyrosine decarboxylase and motor response complications in Parkinson's disease	12
Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysis	12
Increased blood-derived mitochondrial DNA copy number in African ancestry individuals with Parkinson's disease	12
Motor band sign in a Huntington disease phenocopy	12
Grey matter correlates of dystonic soft signs in essential tremor	12
Dopaminergic connectivity reconfiguration in the dementia with Lewy bodies continuum	12
Real-world effect of age on long-term effectiveness and safety of levodopa-carbidopa intestinal gel: post hoc analysis from the DUOGLOBE study	12
Tongue strength in progressive supranuclear palsy	12
The effects of once-daily opicapone 50 mg on the pharmacokinetics of levodopa administered as carbidopa/levodopa extended-release capsules: an open-label study	12
Analysis of GIPC1 CGG repeat expansions in essential tremor	12
Expanding the genotype-phenotype landscape of PDE10A-associated movement disorders	12
“A man with an arched back”: Expert commentary	12
Attainment of physiologic salivary flow rate with long-term incobotulinumtoxinA treatment for sialorrhea in Parkinson’s disease and other neurologic conditions	12
Reliability of remote video ratings of the scale for assessment and rating of ataxia	12
Late-onset parkinsonism in a patient with a novel frameshift THAP1 variant	12
Response to levodopa in Parkinson's disease over time. A 4-year follow-up study	12
MRgFUS of the nucleus ventralis intermedius in essential tremor modulates functional connectivity within the classical tremor network and beyond	11
Ethnoracial differences for caregiving burden in Parkinson’s disease	11
Opicapone Effect on Sleep Disorders in Fluctuating Parkinson’s Disease Patients: Findings from the OASIS Trial	11
Right to the Point - A Writer’s Cramp Successful Treatment	11
Sensor-based gait analysis in the premotor stage of LRRK2 G2019S-associated Parkinson's disease	11
Subjective cognitive complaints are important in PD-MCI criteria: Associations with CSF markers and cognitive decline	11
Sex differences in the association between nonalcoholic fatty liver disease and Parkinson's disease	11
Magnetic Resonance Imaging Marker for the Conversion from Idiopathic Late-onset Cerebellar Ataxia to Multiple System Atrophy	11
Development of a screening AI model for Parkinson's disease using gait image sequences	11
WITHDRAWN	11
Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for Parkinson’s disease: Three-year data from the open-label BeyoND study	11
Patients with progressive supranuclear palsy need to be seen sooner and more frequently	11
Editorial Board	11
A case of treatable encephalopathy, developmental regression, and proximal tremor: Expert commentary	11
Association between cognitive adverse effects of anticholinergic medication and development of dementia in Parkinson’s disease	11
The use of hypoglycemic drugs in Parkinson's disease: An updated meta-analysis of randomized controlled trials	11
Usage of modern technologies like VR therapy, physio therapy along with levodopa in Young-Onset Parkinson's disease patients	11
A structural perspective on the interaction between glucocerebrosidase and the positive allosteric modulator BIA 28-6156	11
Accelerometric quantification of MDS-UPDRS bradykinesia measurements in PD patients: A pilot study	11
Comparison of tetrabenazine, tiapride and olanzapine in Huntington's disease: a one-year French randomized multicenter study (Neuro-HD)	11
Comment on “Defining ‘OFF’ time in device-aided therapy criteria for Parkinson's disease: Gaps and opportunities”	11
Empowering the management of early-onset Parkinson’s disease: The role of technology	11
Challenges during prayer (namaz/salah) rituals in Muslim patients with Parkinson’s disease	10
Calcium channel blockers and Parkinson's disease: A systematic review and meta-analysis	10
A case of treatable encephalopathy, developmental regression, and proximal tremor	10
tDCS application for postural control in Parkinson's disease: Effects are associated with baseline characteristics	10
TMS-evoked potentials provide novel neurophysiological features of Tourette syndrome	10
Symptom changes with hormonal variations in genetic dystonia	10
Real-world local field potential recordings in patients with deep brain stimulation for Parkinson's disease	10
Utility of clinical tests for asymmetry in Parkinson's disease and Atypical Parkinsonian disorders: the PARK-SYMM scale study.	10
TorsinA-interacting protein 2 (TOR1AIP2) variants in an autosomal dominant combined dystonia-hemichorea-hemiballismus syndrome in two families	10
Exposure factors and clinical characteristics associated with Parkinson's disease in GBA1 variant carriers: A Chinese GBA1-PD intrafamilial survey	10
Profile of patients with advanced Parkinson’s disease treated with Levodopa–entacapone–carbidopa intestinal gel (LECIG)	10
A Novel Missense Mutation in the Spectrin Repeat of SPTBN2 Identified in Spinocerebellar Ataxia Type 5	10
Enhanced low beta activity in Park2-associated Parkinson’s disease	10
Demonstration of a Prototype Clinical Decision Support System for Diagnosing Parkinson’s Disease	10
Exploring Novel Therapeutic Approaches in Parkinson’s Disease: A Comprehensive Review	10
Assessment of Cerebral Cortical Atrophy Using Visual Rating Scale in Patients with Functional Movement Disorder	10
Multiple system atrophy like presentation with hot-cross bun sign in anti-IgLON5 disease	10
Analysis of interleukin-6 levels in patients with Parkinson's disease by disease stage	10
A benign course of Parkinson's disease associated with different mutations in the glucocerebrosidase gene – A case series	10
The use of botulinum toxin A in the treatment of hand tremor	10
An atypical case of head tremor	10
A challenging case of cerebellar ataxia associated with oro facial dominant chorea	10
High preoperative gait variability is a prognostic predictor of gait and balance in Parkinson disease patients with deep brain stimulation	10
Influence of Toxic Exposure on the Age of Onset of Parkinson's Disease: An Observational and Analytical Study.	10
Developing a Female-Specific Mouse Model for Parkinson’s Disease Using a High-Sensitivity Neural Network	10
The iNPH Radscale May Better Predict Whether Ventriculoperitonal Shunting was Offered, Compared to Drain Trial Gait Variables	10
Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies	10
The influence of fatigue on motor imagery ability in people with Parkinson’s disease – preliminary study	10
Non-pharmacological rehabilitation for people living with advanced Parkinson's disease: A scoping review of interventions	10
Real world evidence of efficacy ad safety of subcutaneus foslevodopa/foscarbidopa infusion in advanced Parkinson disease	9
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation	9
Diagnosis across a cohort of “atypical” atypical and complex parkinsonism	9
Double blind, nonrandomized crossover study of active recharge biphasic deep brain stimulation for primary dystonia	9
Structural and functional brain abnormalities in idiopathic cervical dystonia: a multimodal meta-analysis	9
Preliminary verification of a Kinect-based system for evaluating postural abnormalities in patients with Parkinson’s disease	9
Long-term safety of continuous levodopa/carbidopa infusion with ND0612: results from the ongoing BeyoND study	9
Editorial Board	9
Efficacy of Probiotics for treatment of constipation in Parkinson’s patients: a systematic review and meta-analysis	9
A multidisciplinary telemedicine approach for managing frailty in Parkinson's disease. A longitudinal, case-control study	9
Backward leaning during gait: An underrecognized sign in Niemann-Pick type C	9
Development of osteomyelitis after COVID 19 in patients with vascular parkinsonism	9
Leucine-rich repeat kinase2 (LRRK2) associated Parkinson's disease: less vulnerable during Covid-19 pandemic?	9
A case of levodopa responsive parkinsonism due to methanol toxicity, an impact of COVID-19 crisis	9
Clinical progression of vascular Parkinsonism in ischemic stroke patients with metabolic syndrome	9
Other clinical uses for apomorphine: Sedation and sleep disorders, withdrawal of oral dopaminergic medication, palliative care, restless legs syndrome, traumatic brain injury, sexual dysfunction	9
Clinical correlations of cerebrospinal fluid biomarkers including neuron-glia 2 and neurofilament light chain in patients with multiple system atrophy	9
Inter-muscular coherence in speed skaters with skater's cramp	9
Comparison of voice parameters, self-assessment of speech and sialorrhea levels in Parkinson's disease patients with and without swallowing problems	9
Utilizing technology-based outcome measures in the natural setting to answer intriguing clinical questions in Parkinson disease	9
A novel GNAL pathogenic variant leading to generalized dystonia: Immediate and sustained response to globus pallidus internus deep brain stimulation	9
Magnetic Resonance–Guided focused ultrasound surgery for Parkinson's disease: A mini-review and comparison between deep brain stimulation	8
The impact of dysphagia in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel	8
Diagnosis of Parkinson's disease from hand drawing utilizing hybrid models	8
Resting-state EEG predicts cognitive decline in a neuropathologically diagnosed longitudinal community autopsied cohort	8
Update: Protective and risk factors for Parkinson disease	8